metricas
covid
Clinics Programmed cell death-1 and its ligands: Current knowledge and possibilities in ...
Journal Information

Statistics

Follow this link to access the full text of the article

Review articles
Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy
Bojana Gutica, Tatjana Bozanovicb, Aljosa Mandica, Stefan Dugalicb, Jovana Todorovicc, Dejana Stanisavljevicd, Miroslava Gojnic Dugalicb, Demet Sengule, Dzenana A. Detanacf, Ilker Sengulg,h,
Corresponding author
ilker.sengul.52@gmail.com

Corresponding author.
, Dzemail Detanaci, José Maria Soares Juniorj
a Oncology Institute of Vojvodina, Faculty of Medicine University Novi Sad, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
b Department of Gynecology and Obstetrics, University Clinical Center of Serbia, Clinic for Gynecology and Obstetrics, Belgrade, Serbia
c Institute for Social Medicine, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
d Institute for Statistics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
e Department of Pathology, Faculty of Medicine, Giresun University, Giresun, Turkey
f Department of Ophthalmology, General Hospital Novi Pazar, Novi Pazar, Serbia
g Division of Endocrine Surgery, Faculty of Medicine, Giresun University, Giresun, Turkey
h Department of Surgery, Faculty of Medicine, Giresun University, Giresun, Turkey
i Department of Surgery, General Hospital Novi Pazar, Novi Pazar, Serbia
j Disciplina de Ginecologia, Departamento de Obsetrícia e Ginecologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
Ver más
Read
2183
Times
was read the article
431
Total PDF
1752
Total HTML
Share statistics
Article information
ISSN: 18075932
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 46 4 50
2025 11 205 34 239
2025 10 83 11 94
2025 9 75 16 91
2025 8 100 10 110
2025 7 88 7 95
2025 6 82 2 84
2025 5 59 4 63
2025 4 44 6 50
2025 3 58 2 60
2025 2 32 1 33
2025 1 34 5 39
2024 12 37 4 41
2024 11 67 20 87
2024 10 54 29 83
2024 9 74 36 110
2024 8 68 35 103
2024 7 62 40 102
2024 6 83 39 122
2024 5 123 21 144
2024 4 57 21 78
2024 3 73 16 89
2024 2 57 17 74
2024 1 59 21 80
2023 12 32 30 62
Show all

Follow this link to access the full text of the article